Gemtuzumab and febrile neutropenia Patient Reports February 13, 2012

Gemtuzumab Side Effects Report #4699549-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from on June 15, 2005. Male patient, 49 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, phlebitis. Gemtuzumab dosage: 6 MG/M^2X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4700458-4
Gemtuzumab side effect was reported by a Consumer or non-health professional from on June 20, 2005. Male patient, 49 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, phlebitis. Gemtuzumab dosage: 6 MG/M^2 1X PER 1 DAY, INTRAVANEOUS. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4808987-X
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Oct 13, 2005. Male patient, 49 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, phlebitis. Gemtuzumab dosage: 6 MG/M^2 1X PER 1 DAY INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4823384-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Oct 27, 2005. Male patient, 49 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, phlebitis. Gemtuzumab dosage: 6 MG/M^2 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.


Gemtuzumab Side Effects Report #4978389-4
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Apr 07, 2006. Male patient, 40 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, febrile neutropenia, portal vein thrombosis. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4979712-7
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Apr 07, 2006. Male patient, 40 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, febrile neutropenia, portal vein thrombosis. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4830694-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Oct 31, 2005. Male patient, 27 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: cellulitis , febrile neutropenia, white blood cell count decreased. Gemtuzumab dosage: 6 MG/M^2 1X PER 1 MTH, INTRAVENOUS. During the same period patient was treated with VORICONAZOLE, CEFIXIME. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5096613-7
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Aug 21, 2006. Male patient, child 8 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cholecystitis acute, cystitis haemorrhagic, febrile neutropenia, malignant neoplasm progression. Gemtuzumab dosage: 9 MG/M^2 1X PER 1 DAY; DAYS 1 AND 14. Patient recovered.

Gemtuzumab Side Effects Report #4745019-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from NETHERLANDS on Aug 04, 2005. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: cellulitis , escherichia sepsis, febrile neutropenia, prostatitis. Gemtuzumab dosage: 6 MG/M^2 1X PER 1 DAY. Patient was hospitalized. Patient recovered.


Gemtuzumab Side Effects Report #4907159-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from TURKEY on Jan 23, 2006. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: budd-chiari syndrome, diarrhoea, febrile neutropenia, gastrointestinal haemorrhage, respiratory tract infection fungal. Gemtuzumab dosage: 10 MG 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, LEVOTHYROXINE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4869294-2
Gemtuzumab side effect was reported by a Health Professional from AUSTRALIA on Aug 22, 2002. Female patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bundle branch block, cardiac failure congestive, chest pain , diarrhoea, febrile neutropenia, fluid retention, gingivitis, pancytopenia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE, PARACETAMOL, PROMETHAZINE HYDROCHLORIDE, ALLOPURINOL, FUROSEMIDE, HYDROCORTISONE, ESTRADIOL. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #4867731-0
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2002. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4867732-2
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2002. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: cellulitis , febrile neutropenia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4843539-7
Gemtuzumab side effect was reported by a Physician from UNITED STATES on Jan 12, 1998. Female patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, hypotension. Gemtuzumab dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS. Patient was hospitalized. Patient recovered.


Gemtuzumab Side Effects Report #4853930-0
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 03, 2005. Female patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, hypotension. Gemtuzumab dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #6016457-9
Gemtuzumab side effect was reported by a Physician from DENMARK on Dec 18, 2008. Female patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aplastic anaemia, azotaemia, blood test abnormal, clostridial infection, febrile neutropenia, haemoglobinuria, intravascular haemolysis, sepsis . Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, AMSACRINE. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4911211-0
Gemtuzumab side effect was reported by a Consumer or non-health professional from AUSTRALIA on Jan 15, 2002. Male patient, 41 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, blood urea increased, diarrhoea, febrile neutropenia, gastrointestinal haemorrhage, hepatic cyst, laboratory test abnormal, melaena. Gemtuzumab dosage: 9 MG/M^2 1X PER DOS, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient died.

Gemtuzumab Side Effects Report #4867128-3
Gemtuzumab side effect was reported by a Physician from FRANCE on Mar 10, 2002. Male patient, 40 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aplasia, cerebral haemorrhage, coma, febrile neutropenia, haemorrhagic stroke, hyperthermia, malaise, thrombocytopenia, white blood cell count decreased. Gemtuzumab dosage: 9 MG/M (2) [18 MG] INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, ALIZAPRIDE, PIPERACILLIN W, CLORAZEPATE, COLISTIN, CISAPRIDE. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #4867716-4
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2002. Male patient, 40 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.


Gemtuzumab Side Effects Report #5246876-X
Gemtuzumab side effect was reported by a Physician from NETHERLANDS on Feb 14, 2007. Female patient was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchitis , diarrhoea, fatigue, febrile neutropenia, nausea . Gemtuzumab dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, MAALOX FAST BLOCKER. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5353990-7
Gemtuzumab side effect was reported by a Physician from ITALY on June 07, 2007. Male patient, weighting 147.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac arrest , enteritis, febrile neutropenia. Gemtuzumab dosage: ACTUAL DOSE GIVEN .051 MG (CUMULATIVE DOSE GIVEN 15.500 MG). During the same period patient was treated with TAZOCIN, AMIODARONE, VFEND, IDARUBICIN. Patient was hospitalized. Patient died on 05/30/2007.

Gemtuzumab Side Effects Report #5366964-7
Gemtuzumab side effect was reported by a Physician from ITALY on June 19, 2007. Male patient, weighting 147.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac arrest , enteritis, febrile neutropenia. Gemtuzumab dosage: ACTUAL DOSE GIVEN .051 MG (CUMULATIVE DOSE GIVEN 15.500 MG). During the same period patient was treated with IDARUBICIN, TAZOCIN, CYTARABINE. Patient was hospitalized. Patient died on 05/30/2007.

Gemtuzumab Side Effects Report #5445027-6
Gemtuzumab side effect was reported by a Physician from ITALY on Sept 03, 2007. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, septic shock. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient died on 08/21/2007.

Gemtuzumab Side Effects Report #5535219-X
Gemtuzumab side effect was reported by a Physician from ITALY on Nov 26, 2007. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, septic shock. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, METHYLPREDNISOLONE, MEROPENEM. Patient died on 08/21/2007.


Gemtuzumab Side Effects Report #4802362-X
Gemtuzumab side effect was reported by a Consumer or non-health professional from BELGIUM on Sept 30, 2005. Female patient, 69 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood fibrinogen increased, febrile neutropenia, fibrin d dimer increased, haematocrit decreased, haemoglobin decreased, hypoxia, lymphocyte count increased, neutrophil count decreased. Gemtuzumab dosage: 14 MG. During the same period patient was treated with ALIZAPRIDE, BUMETANIDE, PETHIDINE HYDROCHLORIDE. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #4805266-1
Gemtuzumab side effect was reported by a Consumer or non-health professional from BELGIUM on Oct 12, 2005. Female patient, 69 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood fibrinogen increased, c-reactive protein increased, febrile neutropenia, fibrin d dimer increased, haematocrit decreased, haemoglobin decreased, hypoxia, lymphocyte count increased. Gemtuzumab dosage: 14 MG. During the same period patient was treated with ALIZAPRIDE, BUMETANIDE, PETHIDINE HYDROCHLORIDE. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #4714314-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from NETHERLANDS on June 29, 2005. Female patient, 68 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: escherichia urinary tract infection, febrile neutropenia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.